BioSpace News Archive

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced fourth quarter and full year 2020 financial results.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the closing of its previously announced underwritten public offering of 12,500,000 shares of its common stock,

Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced its financial and operating results for the three and nine months ended December 31, 2020. All dollar amounts below are in Canadian dollars unless specified otherwise. Third Quarter Fiscal 2021 Financial Highlights:

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading provider of surgical services, today announced that Dr. Patricia A. Maryland has been appointed to serve as an independent director on its Board of Directors.

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report fiscal 2020 financial results on Tuesday, March 9, 2021 at 4:45PM EST .

AQUARIUS SURGICAL TECHNOLOGIES INC. reports the results of operations for the nine-month period ended December 31, 2020.

Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the formation of an independent Scientific Advisory Board comprising leaders in the fields of immunotherapy, lung and skin cancers.

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that it will participate in the following investor conferences in the month of March, with presentations led by the Company’s President and Chief Executive Officer, Rodney Varner.

ATW Tech Inc. (the “Company” or “ATW Tech”) (TSX-V: ATW) is pleased to announce the appointment of Mr. Christian Trudeau as Chairman of the Board of Directors of the Company to replace Mr. Michel Guay, who was holding the position on an interim basis.

AllianceRx Walgreens Prime recently announced results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost